CNSX:CBIS

Stock Analysis Report

Executive Summary

Cannabis One Holdings Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Share Price & News

How has Cannabis One Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-8.7%

CBIS

-9.2%

CA Pharmaceuticals

-0.1%

CA Market


1 Year Return

n/a

CBIS

-60.2%

CA Pharmaceuticals

0.9%

CA Market

Return vs Industry: Insufficient data to determine how CBIS performed against the Canadian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CBIS performed against the Canadian Market.


Shareholder returns

CBISIndustryMarket
7 Day-8.7%-9.2%-0.1%
30 Day-40.0%-26.9%-2.1%
90 Day-65.0%-37.2%-1.6%
1 Yearn/a-60.2%-60.2%4.4%0.9%
3 Yearn/a77.3%76.0%15.5%5.2%
5 Yearn/a266.3%266.3%25.7%7.5%

Price Volatility Vs. Market

How volatile is Cannabis One Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Cannabis One Holdings undervalued compared to its fair value and its price relative to the market?

1.06x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate CBIS's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate CBIS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CBIS is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.

PE vs Market: CBIS is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate CBIS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CBIS is good value based on its PB Ratio (1.1x) compared to the CA Pharmaceuticals industry average (1.9x).


Next Steps

Future Growth

How is Cannabis One Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

89.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cannabis One Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Cannabis One Holdings performed over the past 5 years?

-861.0%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CBIS is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.

Accelerating Growth: Unable to compare CBIS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CBIS is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (15.6%).


Return on Equity

High ROE: CBIS has a negative Return on Equity (-21.52%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: CBIS is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: CBIS is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Cannabis One Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: CBIS's short term assets ($6.4M) exceeds its short term liabilities ($1.0M)

Long Term Liabilities: CBIS has no long term liabilities


Debt to Equity History and Analysis

Debt Level: CBIS is debt free.

Reducing Debt: CBIS had no debt 5 years ago.


Balance Sheet

Inventory Level: CBIS has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if CBIS's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if CBIS has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CBIS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Cannabis One Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%6.0%industryaverage2.8%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate CBIS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CBIS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CBIS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CBIS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CBIS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Cannabis One Holdings's salary, the management and board of directors tenure and is there insider trading?

0.4yrs

Average management tenure


CEO

Jeffery Mascio 0

0yrs

Tenure

0

Mr. Jeffery Allan Mascio serves as Chief Executive Officer & Director of Cannabis One Holdings Inc. formerly known as Bertram Capital Finance Inc since July 2019. He served as Chairman of the Board & Presi ...


Management Age and Tenure

0.4yrs

Average Tenure

Experienced Management: CBIS's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.


Insider Trading

Insider Buying: CBIS insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$25,00007 Oct 19
Wildhorse Capital Partners Inc
EntityCompany
Shares62,500
Max PriceUS$0.40
BuyUS$2,00002 Oct 19
Joshua Mann
EntityIndividual
Role
Member of the Board of Directors
President & Director
Shares10,000
Max PriceUS$0.20
BuyUS$7,44428 Aug 19
Darrick Payne
EntityIndividual
Role
Member of the Board of Directors
VP of Compliance & Director
Shares20,000
Max PriceUS$0.37
BuyUS$4,48531 Jul 19
Joshua Mann
EntityIndividual
Role
Member of the Board of Directors
President & Director
Shares10,500
Max PriceUS$0.47
BuyUS$6,43419 Jun 19
Patrick Rinker
EntityIndividual
Shares5,000
Max PriceUS$1.29
BuyUS$58412 Jun 19
Patrick Rinker
EntityIndividual
Shares400
Max PriceUS$1.46
BuyUS$1,27705 Jun 19
Bradley Harris
EntityIndividual
Role
Member of the Board of Directors
VP of Retail Operations & Director
Shares900
Max PriceUS$1.42
BuyUS$21,39528 May 19
Christopher Fenn
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares6,700
Max PriceUS$3.41
BuyUS$50,99827 May 19
Wildhorse Capital Partners Inc
EntityCompany
Shares18,500
Max PriceUS$3.73

Ownership Breakdown


Management Team

  • Josh Mann

    President & Director

    • Tenure: 0yrs
  • Jeffery Mascio

    CEO & Director

    • Tenure: 0yrs
  • Brad Harris

    VP of Retail Operations & Director

    • Tenure: 0yrs
  • Darrick Payne

    VP of Compliance & Director

    • Tenure: 0yrs
  • Ryan Atkins

    General Counsel

    • Tenure: 0.4yrs
  • Theresa Mohan

    Interim Chief Financial Officer

    • Tenure: 0.4yrs

Board Members

  • Josh Mann

    President & Director

    • Tenure: 0yrs
  • Jeffery Mascio

    CEO & Director

    • Tenure: 0yrs
  • Brad Harris

    VP of Retail Operations & Director

    • Tenure: 0yrs
  • Chris Fenn

    Chairman of the Board

    • Tenure: 0.3yrs
  • Darrick Payne

    VP of Compliance & Director

    • Tenure: 0yrs

Company Information

Cannabis One Holdings Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cannabis One Holdings Inc.
  • Ticker: CBIS
  • Exchange: CNSX
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$24.856m
  • Shares outstanding: 118.36m
  • Website: https://www.cannabisone.life

Location

  • Cannabis One Holdings Inc.
  • 700 West Pender Street
  • Suite 610
  • Vancouver
  • British Columbia
  • V6C 1G8
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CBISCNSX (Canadian National Stock Exchange)YesClass A Subordinated Voting SharesCACADFeb 2019
CAAO.FOTCPK (Pink Sheets LLC)YesClass A Subordinated Voting SharesUSUSDFeb 2019
3YXMUN (Boerse Muenchen)YesClass A Subordinated Voting SharesDEEURFeb 2019

Biography

Cannabis One Holdings Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the Unit ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 00:44
End of Day Share Price2019/10/11 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.